0001209191-23-006388.txt : 20230202
0001209191-23-006388.hdr.sgml : 20230202
20230202182126
ACCESSION NUMBER: 0001209191-23-006388
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230131
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wong Brian Russell
CENTRAL INDEX KEY: 0001646110
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 23582799
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCICO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-31
0
0001673772
RAPT Therapeutics, Inc.
RAPT
0001646110
Wong Brian Russell
C/O RAPT THERAPEUTICS, INC.
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Employee Stock Option (right to buy)
29.05
2023-01-31
4
A
0
250000
0.00
A
2033-01-30
Common Stock
250000
250000
D
1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of to January 1, 2023.
/s/ Rodney Young, Attorney-in-Fact for Brian Russell Wong, M.D., Ph.D.
2023-02-02